Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Policosanol helps treat hair loss by balancing hormones and supporting hair growth.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Lower SHBG levels may increase the risk of PCOS.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

Gray hair regained color after thyroid hormone treatment.

The study aims to create a model to improve personalized and preventive health care.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.